14 Analysts Have This to Say About Biomea Fusion
Portfolio Pulse from Benzinga Insights
14 analysts have provided ratings for Biomea Fusion (NASDAQ:BMEA) in the last quarter, with 10 being bullish, 3 somewhat bullish, and 1 indifferent. The average 12-month price target for the company is $45.43, an increase of 6.27% from the previous average of $42.75.
July 25, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts are generally bullish on Biomea Fusion with an increased average 12-month price target.
The majority of analysts are bullish on Biomea Fusion, indicating a positive sentiment towards the company. The increased average 12-month price target suggests that analysts expect the company's stock price to rise in the future.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100